US 10,894,815 B2Granted

Compositions and methods for treating heart failure in diabetic patients

AssigneeZensun (Shanghai) Science & Technology, Co., Ltd.

InventorMingdong Zhou

Life of this patent

Estimating the term…

Abstract

The present invention provides the use of neuregulin protein for the preparation of medication for preventing, treating or delaying heart failure in humans and methods for preventing, treating or delaying heart failure in humans using said medication.

Claims9

Dependent claims

A method of treating cardiac complications in a human diabetic patient, comprising administering a pharmaceutical composition comprising an effective amount of neuregulin to the patient, wherein the neuregulin comprises SEQ ID NO:

Dependencies are inferred from the claim text.

Facts

Application: 14/429,750Filed 8 Oct 2012
Published: US 2015/0284440 A18 Oct 2015
Granted: 19 Jan 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

C07K 14/4756
Growth factors; Growth regulators: neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
C13K 13/002
Sugars not otherwise provided for in this class: xylose
A61K 38/1883
Growth factors; Growth regulators: neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
A61P 3/10
For glucose homeostasis: for hyperglycaemia, e.g. antidiabetics

Family

US 2015/0284440 A1Pre-grant publication · published 8 Oct 2015
US 10,894,815 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results